$IDRA Headlines Six stocks to watch 4:27 p.m. Feb. 26,

New Post Public Reply Private Reply Replies (0) Message Board

Mar 11, 2014 at 11:49 AM

$IDRA Headlines

Six stocks to watch 4:27 p.m. Feb. 26, 2014 - The Trading Deck
S&P 500 rattles the cage on latest all-time high 12:28 p.m. Feb. 24, 2014 - Michael Ashbaugh
Bears chip away at the S&P 1,775 support 12:01 p.m. Feb. 3, 2014 - Michael Ashbaugh
Charting a bullish early-2014 outlook 1:05 p.m. Dec. 31, 2013 - Michael Ashbaugh
Charting a bullish early-2014 outlook 12:39 p.m. Dec. 31, 2013 - Michael Ashbaugh
S&P, Nasdaq rally from major support 12:09 p.m. Dec. 16, 2013 - Michael Ashbaugh
Pfizer, Affymetrix weigh on drug stocks 3:04 p.m. July 7, 2011 - Val Brickates Kennedy
Idera tumbles 14% on drug setback 2:52 p.m. July 7, 2011 - Val Brickates Kennedy
Tuesday's biggest gaining and declining stocks 5:37 p.m. Jan. 19, 2010 - MarketWatch
Incyte, Idera move on Novartis deals 3:02 p.m. Nov. 25, 2009 - Val Brickates Kennedy
Novartis terminates pact with Idera 9:28 a.m. Nov. 25, 2009 - Val Brickates Kennedy
Wednesday's biggest gaining and declining stocks 5:29 p.m. Dec. 26, 2007 - MarketWatch
Idera Pharmaceuticals' president, Karr, resigns 10:08 a.m. Dec. 26, 2007 - Robert Daniel
Idera Pharma President Karr resigns, stays on board 10:03 a.m. Dec. 26, 2007 - Robert Daniel
Idera signs agonist licensing, collaboration with Merck KGaA 8:10 a.m. Dec. 19, 2007 - Sarah Turner
Idera to get up to $381 mln in milestones 8:03 a.m. Dec. 19, 2007 - Steve Goldstein
Idera, Merck KGaA agree collaboration deal 8:02 a.m. Dec. 19, 2007 - Steve Goldstein
Wednesday's biggest stock gainers and decliners 7:03 p.m. Feb. 28, 2007 - Michael Baron
Idera Pharma started at buy at Merriman Curhan Ford 9:54 a.m. Feb. 7, 2007 - Tomi Kilgore
Drug stocks slip; Nuvelo, Neopharm shares plunge on trial results 5:37 p.m. Dec. 11, 2006 - Carolyn Pritchard

Idera: A Compelling Biotech Pick For March 11:34 a.m. March 7, 2014 - Seeking Alpha
3 Small Cap Biotechs With Near-Term Catalysts 10:25 a.m. March 6, 2014 - Seeking Alpha
Interesting IDRA Put And Call Options For April 19th 12:01 p.m. Feb. 26, 2014 - TheStreet.com
Idera Pharmaceuticals (IDRA) Showing Signs Of Perilous Reversal Today 10:53 a.m. Feb. 24, 2014 - TheStreet.com
Idera Pharmaceuticals: Set To Ride A 200% Gain In 2014 10:38 a.m. Jan. 31, 2014 - Seeking Alpha
Idera Pharmaceuticals Presents a Promising Opportunity 3:23 p.m. Dec. 26, 2013 - Wall St. Cheat Sheet
Friday’s Biggest Stock Losers: INSY OPK, and More 8:52 a.m. Dec. 13, 2013 - InvestorPlace.com
9 Biotechnology Stocks to Buy Now 7:00 a.m. Dec. 11, 2013 - InvestorPlace.com
10-Q: IDERA PHARMACEUTICALS, INC. 8:02 a.m. Nov. 14, 2013 - Edgar Online - (EDG = 10Q, 10K)
Biotech-Focused Baker Bros. Accumulates These 3 Stocks 9:55 a.m. Oct. 1, 2013 - Seeking Alpha
Idera Phase 2 Data Provides For Exciting Q4 2013 And Q1 2014 9:02 a.m. Sept. 25, 2013 - Seeking Alpha
Analysts: Blackstone Mortgage Gaining Traction and 3 Other Research Notes to Browse 2:37 p.m. Aug. 29, 2013 - Wall St. Cheat Sheet
Idera Enters Agreement with NCI to Evaluate Use of TLR Antagonists for Treatment of Genetically Defined Lymphomas 7:39 a.m. Aug. 29, 2013 - benzinga.com
Idera Announces Issuance of US Patent Covering IMO-8400, Lead Candidate in Phase 2 Trial 7:05 a.m. July 18, 2013 - benzinga.com
Idera Pharma to Issue Positive Phase I Trial Results on TLR Antagonist IMO-8400 6:31 a.m. June 21, 2013 - benzinga.com
Idera Pharmaceuticals Announces Initiation of a Phase 2 Trial of IMO-8400 in Patients with Moderate to Severe Plaque Psoriasis 7:07 a.m. June 5, 2013 - benzinga.com
10-Q: IDERA PHARMACEUTICALS, INC. 7:49 a.m. May 15, 2013 - Edgar Online - (EDG = 10Q, 10K)
Idera Pharmaceuticals Announces Closing of Common Share Offering 3:19 p.m. May 7, 2013 - benzinga.com
Idera Pharmaceuticals Prices 17.5M Share Offering at $0.50/Share 4:59 a.m. May 2, 2013 - benzinga.com
1 Stock to Buy, 1 Stock to Short: Penny Stocks 9:52 a.m. April 16, 2013 - InvestorPlace.com

Idera to Host Conference Call and Webcast to Report Fourth Quarter and Full Year 2013 Financial Results on Thursday, March 13, 2014 9:31 a.m. March 6, 2014 - BusinessWire - BZX
Idera to Present at the Cowen & Co. 34th Annual Health Care Conference 9:31 a.m. Feb. 26, 2014 - BusinessWire - BZX
Idera to Present at the 2014 RBC Capital Markets’ Global Healthcare Conference 5:02 p.m. Feb. 18, 2014 - BusinessWire - BZX
Idera Pharmaceuticals Announces Closing of Public Offering of Common Stock and Pre-Funded Warrants 5:15 p.m. Feb. 10, 2014 - BusinessWire - BZX
Idera to Present at 16th Annual BIO CEO & Investor Conference 9:30 a.m. Feb. 6, 2014 - BusinessWire - BZX
Idera Pharmaceuticals Announces Pricing of Public Offering of Common Stockand Pre-Funded Warrants 10:10 a.m. Feb. 5, 2014 - BusinessWire - BZX
Idera Pharmaceuticals Announces Public Offering of Common Stock and Pre-Funded Warrants 5:01 p.m. Feb. 4, 2014 - BusinessWire - BZX
Idera Announces Publication of New Data Demonstrating Impact of Inhibiting TLRs 7, 8, and 9 in a Preclinical Model of Autoimmune Disease 9:01 a.m. Jan. 22, 2014 - BusinessWire - BZX
Healthcare Companies Report Conference Presentation Schedule, Stock Price Updates, and Clinical Study Results - Research Report on Medivation, Envision Healthcare, Fonar, Idera Pharma, and Neurocrine 9:00 a.m. Jan. 9, 2014 - PR Newswire
Idera Expands Leadership Team and Strengthens Clinical Development Expertise in Oncology and Orphan Diseases 9:00 a.m. Jan. 9, 2014 - BusinessWire
Relocation Plans, Patient Enrollment, Management Appointments, and Price Movements - Research Report on HCA Holdings, Opko Health, Santarus, Coronado, and Idera 9:00 a.m. Dec. 31, 2013 - PR Newswire
Senior Appointments, Stock Splits, New Guidelines, Positive Results, and Clinical Trial Updates - Research Report on Receptos, MEDNAX, CombiMatrix, Anacor, and Idera 9:00 a.m. Dec. 10, 2013 - PR Newswire
Idera Pharmaceuticals Opens Enrollment for Phase 1/2 Clinical Trial of IMO-8400 in Waldenstrom's Macroglobulinemia 8:30 a.m. Dec. 4, 2013 - BusinessWire
Idera Pharmaceuticals to Present at the 25th Annual Piper Jaffray Healthcare Conference 5:02 p.m. Nov. 25, 2013 - BusinessWire
Idera Pharmaceuticals Reports Third Quarter 2013 Financial Results and Provides Corporate Update 8:45 a.m. Nov. 14, 2013 - BusinessWire
Idera Pharmaceuticals to Host Conference Call to Report Third Quarter 2013 Financial Results on Thursday, November 14, 2013 5:10 p.m. Nov. 7, 2013 - BusinessWire
Idera Pharmaceuticals Announces Closing of Public Offering of Common Stock and Pre-Funded Warrants 4:14 p.m. Sept. 30, 2013 - BusinessWire
Idera Pharmaceuticals Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants 9:09 a.m. Sept. 25, 2013 - BusinessWire
Idera Pharmaceuticals Announces Public Offering of Common Stock and Pre-Funded Warrants 4:01 p.m. Sept. 24, 2013 - BusinessWire
Five Star Equities Issues New Research Reports on EZCH, IDRA, PSTI and UNFI 9:01 a.m. Sept. 13, 2013 - ACCESSWIRE

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

PureHealth's Acid Reflux Solutions: An Investor's Insight

Digestive Wellness: The Emerging Opportunity Some days, it feels like everybody's got a gripe about their gut. You nod along at the lunch counter, folks buzzing about digestive this and acid that. But when PureHealth Research pops up with their fancy supplements, well, even the stock market's noisier nonsense starts sounding a bit quieter. They're banking big on the...

SystImmune's Data on Iza-bren Show Promise for Lung Cancer

Stepping into New Territory with SystImmune Amid the cacophony of biotech whispers and the marketplace hum, SystImmune is trotting out something that might just make the folks in lab coats raise an eyebrow. They’ve got new data for Iza-bren—none of that flashy PR chatter—but it's damn promising if you ask me. At the World Conference on Lung Cancer in Seoul,...

PathoSearch: A New Era in Pathology With Visual Search

Revolutionizing Pathology with a Visual Search Engine In an era where time is money and precision is paramount, Aignostics is betting big on transforming the pathology landscape. Today, their announcement of PathoSearch, a visual search engine designed for retrieving comparable diagnosed pathology cases, marks a massive leap towards streamlining the diagnostic process....

Ajman Spotlights Tourism at Arabian Travel Market 2026

Ajman: A Tourism Gem in the Making Swinging into the Arabian Travel Market 2026, Ajman isn't just a footnote in the UAE's tourism playbook anymore, it's gunning for the spotlight. There's a flurry of activity as the Ajman Department of Tourism, Culture and Media rolls up its sleeves to flaunt the emirate's kaleidoscope of attractions to the world's tourism brass. Going...

Larry Ellison's Moves Signal Confidence in Oracle's Future

Unraveling Ellison's Bold Decision There's nothing like a sudden shift from a tech titan to make Wall Street sit up and take notice. Today, we got the word that Larry Ellison, Oracle's big gun as Executive Chair and CTO, has pulled the plug on his plan to sell Oracle stock. No dice, no distance covered under that plan. And he's made it crystal clear—selling isn't on his...

ARTiSTORY's Strategic Advance in Cultural IP Licensing

Call it a seismic shift or call it common sense, but ARTiSTORY's recent haul of accolades makes it clear: they're onto something big in the cultural IP game. Receiving four honors at the 26th International Advertising Institute Awards (IAI Awards), including a Gold for their British Library × CHAGEE collaboration, and jumping into License Global's Top 60, they're staking...

Protecting Teeth: Insights from Endodontist Dr. Joubert

Preserving Our Natural Chompers Digging into the details of endodontic care, you realize how it's the unsung hero in the dental world. And let's face it, teeth don't get happier on their own when there's a problem on the inside. Dr. Christopher Joubert, a wiz on the endodontic front, spills the beans over at HelloNation about how essential these practices are in keeping...

Delhi Pushes Innovation Against Dryland Challenges

Evolution of South-South Agricultural Cooperation Let's just say if there's a time to shine a spotlight on the arid lands of our world, it's now. The Global Drylands Congress 2026 in New Delhi put a sharp focus on scaling agricultural innovation across these thirsty regions. With climate change breathing down our necks, talking shop about food security isn't just for show...

Silk Road Maritime Extends Its Global Reach in 2026

China-Europe Trade Ties Continue to Tighten You ever watch a cargo ship glide into port and think, "There's a piece of the future right there”? Well, that's the scene at Poland’s Gdansk Port, now officially etched into the Silk Road Maritime route. This ain't just a couple of extra boats cutting through choppy waters—it's a great leap forward for a strained global...

Pizza: The Unlikely Symbol of Universal Togetherness

Why Pizza Is More Than Just Food They say a slice of pizza can tell a story. Whether it's a late-night snack amongst college buddies or the centerpiece of a family's Friday tradition, pizza unites like few others can. It morphs from a study aid into a tool for togetherness without skipping a beat, much like a chameleon of the food world. And no one understands this better...